Sino Biopharmaceut (OTCMKTS:SBMFF) Stock Price, News, Analysis & History

$1.98 -0.07 (-3.51 %)
(As of 03/23/2018 02:43 PM ET)
Previous Close$2.05
Today's Range$1.98 - $1.98
52-Week Range$0.78 - $2.14
Volume8,100 shs
Average Volume30,636 shs
Market Capitalization$17.29 billion
P/E RatioN/A
Dividend YieldN/A

About Sino Biopharmaceut (OTCMKTS:SBMFF)

Sino Biopharmaceut logoSino Biopharmaceutical Limited, researches, develops, manufactures, and markets Chinese medicines and chemical medicines in Hong Kong. The company operates through three segments: Modernized Chinese Medicines and Chemical Medicines, Investment, and Others. Its principal products include hepatitis medicines, such as Tianqingganmei injections, Runzhong dispersible tablets, Mingzheng capsules, Tianqingganping enteric capsules, and Ganlixin injections and capsules; and cardio-cerebral medicines comprising Yilunping and Tuotuo tablets, as well as Tianqingning injections; and oncology medicines consisting of Zhiruo, Saiweijian, and Tianqingyitai injections. The company’s principal products also include Orthopedic medicines, which comprise New Ossified Triol capsules and Jiuli tablets; anti-infectious medicines, including Tiance injections; parenteral nutritious medicines, such as Xinhaineng and Fenghaineng fructose injections; respiratory system medicines, including Tianqingsule inhalation powder and Chia Tai Suke tablets; and anorectal medicines comprising Getai tablets. In addition, it develops medicines for treating tumors, analgesia, diabetes, and other diseases; engages in the retail of pharmaceutical products; provides medical management consultancy services; and manufactures, sells, and distributes health food products, as well as is involved in optometry for optical glasses and sale of ophthalmic products. Further, the company provides research and development services; and operates Chia Tai Shaoyang Orthopedic Hospital. Sino Biopharmaceutical Limited was incorporated in 2000 and is headquartered in Wanchai, Hong Kong.

Receive SBMFF News and Ratings via Email

Sign-up to receive the latest news and ratings for SBMFF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry DRUGS


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$2.04 billion
Price / Sales8.18
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding Shares8,425,190,000

Sino Biopharmaceut (OTCMKTS:SBMFF) Frequently Asked Questions

What is Sino Biopharmaceut's stock symbol?

Sino Biopharmaceut trades on the OTCMKTS under the ticker symbol "SBMFF."

Who are some of Sino Biopharmaceut's key competitors?

Has Sino Biopharmaceut been receiving favorable news coverage?

News articles about SBMFF stock have trended somewhat positive on Friday, according to Accern Sentiment. Accern rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Sino Biopharmaceut earned a daily sentiment score of 0.09 on Accern's scale. They also gave news coverage about the company an impact score of 45.11 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

How do I buy shares of Sino Biopharmaceut?

Shares of SBMFF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Sino Biopharmaceut's stock price today?

One share of SBMFF stock can currently be purchased for approximately $1.98.

How big of a company is Sino Biopharmaceut?

Sino Biopharmaceut has a market capitalization of $17.29 billion and generates $2.04 billion in revenue each year. Sino Biopharmaceut employs 18,163 workers across the globe.

How can I contact Sino Biopharmaceut?

Sino Biopharmaceut's mailing address is Rm 4109 Office Tower Convention Plaza 1 Harbour Road Wanchai, Hong Kong K3, . The company can be reached via phone at 852-2802-9886 or via email at [email protected]

MarketBeat Community Rating for Sino Biopharmaceut (SBMFF)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  20 (Vote Outperform)
Underperform Votes:  24 (Vote Underperform)
Total Votes:  44
MarketBeat's community ratings are surveys of what our community members think about Sino Biopharmaceut and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Sino Biopharmaceut (OTCMKTS:SBMFF) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: SellSellSellSell
Consensus Rating Score:
Ratings Breakdown: 1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Sino Biopharmaceut (OTCMKTS:SBMFF) Consensus Price Target History

Price Target History for Sino Biopharmaceut (OTCMKTS:SBMFF)

Sino Biopharmaceut (OTCMKTS:SBMFF) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
4/18/2017Jefferies GroupInitiated CoverageUnderperformView Rating Details
(Data available from 3/23/2016 forward)


Sino Biopharmaceut (OTCMKTS:SBMFF) Earnings History and Estimates Chart

Earnings by Quarter for Sino Biopharmaceut (OTCMKTS:SBMFF)

Sino Biopharmaceut (OTCMKTS SBMFF) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/26/2017Q1 2017$0.01$560.75 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Sino Biopharmaceut (OTCMKTS:SBMFF) Earnings Estimates

Current Year EPS Consensus Estimate: $0.05 EPS
Next Year EPS Consensus Estimate: $0.06 EPS


Dividend History for Sino Biopharmaceut (OTCMKTS:SBMFF)

No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Sino Biopharmaceut (OTCMKTS SBMFF)

No insider trades for this company have been tracked by


Sino Biopharmaceut (OTCMKTS SBMFF) News Headlines


SEC Filings

Sino Biopharmaceut (OTCMKTS:SBMFF) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Financials are not available for this stock.


Sino Biopharmaceut (OTCMKTS SBMFF) Stock Chart for Friday, March, 23, 2018

Loading chart…

This page was last updated on 3/23/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.